skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Female breast cancer is the second most common cancer worldwide in terms of new cases and the leading cause of cancer death in women, according to the Global Cancer Observatory [1]. In women, the number of worldwide cases is predicted to rise from ~2.1 million in 2018 to ~ 3.1 million in 2040, an increase of ~46% [2]. In honor of the San Antonio Breast Cancer Symposium [3], which convenes from December 4-8, 2018, Citeline's oncology team analyzed breast cancer trends from 2008 to 2017 using Trialtrove®.

 

References:

[1] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68(6), 394-424. Available from: http://dx.doi.org/10.3322/caac.21492 [Accessed 29 November 2018].

[2] Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2018). Global Cancer Observatory: Cancer Tomorrow. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today [Accessed 29 November 2018].

[3] San Antonio Breast Cancer Symposium (2018). Available from: https://www.sabcs.org/2018-Overview [Accessed 29 November 2018].

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: